12:00 AM
 | 
Nov 15, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Onco TCS: Began Phase II/III testing

Inex Pharmaceuticals Corp. (TSE:IEX), Vancouver, B.C.
Product: Onco TCS
Business: Cancer
Therapeutic category: Cytotoxic, Cell proliferation
Target:...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >